1 – 3 of 3
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
(
- Contribution to journal › Article
- 2020
-
Mark
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
(
- Contribution to journal › Article
- 2017
-
Mark
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutations
(
- Contribution to journal › Article